Eli Lilly and Co. doesn’t owe royalties to Research Corp. Technologies Inc. for Lilly’s “crown jewel” diabetes treatments, which are made with an ingredient produced using RCT’s licensed technology, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results